Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

ERbeta-selective agonists: Novel therapy for treatment of cholangiocarcinoma

Reference number
Coordinator Karo Bio Aktiebolag
Funding from Vinnova SEK 75 000
Project duration September 2009 - October 2009
Status Completed

Last updated 25 November 2019

Reference number 2009-03304

Page statistics